Polymerase chain reaction (PCR) amplification of the pertussis toxin promoter region was used to detect BordeteUa pertussis infection in nasopharyngeal aspirates collected from 24 infants and children infected with pertussis and 13 adult contacts during an epidemiological study. The sensitivity of this PCR assay was approximately one bacterium, and the assay was specific for B. pertussis in tests with other BordeteUa species and other respiratory pathogens. The pertussis case definition required a cough with a duration of more than 21 days for infants and children and laboratory confirmation by serology as the primary detection method for infants, children, and adults. The sensitivity of PCR and culture on Bordet-Gengou agar medium was assessed with regard to the case definitions. In the group of infants and children (index cases), the sensitivities of the culture and the PCR were 54.1% (13 of 24) and 95.8% (23 of 24), respectively. In the adult group (household contacts), the sensitivities of the two methods were 15.4% (2 of 13) and 61.5% (8 of 13), respectively. PCR combined with pertussis-specific serology appears to be a useful tool for diagnosis of pertussis especially in epidemiological studies.
Pertussis (whooping cough) is an infectious respiratory disease caused by the bacterial species Bordetella pertussis. The widespread use of a classic whole-cell pertussis vaccine led to a spectacular decrease in pertussis morbidity and mortality in the United States (8) and in some European countries, such as France (16) . However, several reports have shown an unexpected resurgence of pertussis in these countries (4) . One hypothesis commonly accepted is that postvaccination immunity wanes with time (9), in part because of the absence of a late vaccination booster or a natural booster. Thus, young children and adults, despite previous immunization, may become susceptible to B. pertussis infection (21) (22) (23) and may disseminate the infection inside their family. As a consequence, unprotected young infants who are not yet immunized because of their age may become infected. These infants are particularly at risk for severe pertussis and complications (8) .
This new epidemiological situation underscores the need for sensitive and rapid methods for diagnosis of pertussis. Diagnosis of pertussis is still difficult because the classic feature of whooping cough (i.e., the whoops) is rarely found in adults and young infants (4) . B. pertussis infection generally presents as a prolonged cough in this population, and paroxysms are often missing, especially in adults and schoolage children. Furthermore, laboratory confirmation is also difficult. Serological testing by enzyme-linked immunosorbent assay (ELISA) (26) or Western blot (immunoblot) (2) with specific B. pertussis antigens, i.e., pertussis toxin (PT), is very sensitive and specific, but a definitive confirmation * Corresponding author. generally requires the comparison of two serum samples collected at 4-week intervals, and such a delay is incompatible with an early diagnosis. Bacterial identification by culture from nasopharyngeal secretions is still considered to be a reference method. However, culture is not sensitive in many routine laboratories, and sensitivity decreases rapidly after the onset of paroxysms (11, 28) . The polymerase chain reaction (PCR) has recently been developed for direct identification of fastidious culture-growing microorganisms and has already been used to improve laboratory diagnosis of many infectious diseases caused by such different pathogens as Mycobacterium tuberculosis (13) , Towoplasma gondii (6), Treponema pallidum subsp. pallidum (12) , Mycoplasma pneumoniae (5) , Legionella spp. (19) , and Leptospira spp. (20) . Thus, PCR, which is rapid and specific, could represent a useful complementary tool in pertussis diagnostic strategy. Two different PCR assays were recently developed for direct identification of B. pertussis (10, 15 thus, serology can be considered to be the primary laboratory method for confirmation of the diagnosis in our study. All 24 infants and children coughed for a duration of longer than 21 days, and all had paroxysms during the course of the disease. The mean duration of coughing at the first visit was 16.4 days (range 8 to 30 days) ( Table 1 ). The ages ranged from 3 Weeks to 12 years (19 of 24 patients were aged less than 6 months), and the sex distribution was 13 boys and 11 girls. Only five of them had previously been immunized with a tetravalent combined diphtheria-tetanus-poliomyelitis-pertussis whole-cell vaccine; one had received four injections (no. 3), one had received three injections (no. 14), and three had received only one injection (no. 4, 5, and 21).
All infants and children underwent a physical examina- 14) each had only one serum sample collected in which anti-PT antibodies were already detected, and no other serum sample was available for comparison. The 19 other children each had two serum samples collected at 4-to 6-week intervals for pertussis serology. The first serum sample was collected early in the disease, during the first visit, and the second serum sample was collected at followup, 4 to 6 weeks later. When available, for young infants aged less than 6 months, a prepartum serum sample, collected from the mother during pregnancy (for rubella or (10) . Proteinase K was then heat inactivated at 100°C for 20 min. Part of the extract (30 ,ul) was used for PCR amplification. Each experiment contained 8 to 10 samples, including two reagent negative control tubes (one containing Tris hydrochloride and proteinase K and one containing sterile water added through the mineral oil) which were used to assess spurious contamination during the procedure.
PCR assay. The oligonucleotide primers, PTp-1 and PTp-2, derived from nucleotides 307 to 332 and 469 to 497 of the respective sense and antisense strands of the PT operon (15) , were Detection of the PCR products. The amplification products were run in parallel with molecular weight markers in a 1% agarose gel stained with ethidium bromide. For greater sensitivity and specificity, the analysis of the PCR products was routinely performed by hybridization with a probe specific for B. pertussis pt promoter. The same oligonucleotide primers (pPT-1 and pPT-2) were used to synthesize this probe in a PCR experiment in which dTTP was replaced by fluorescein-n-dUTP (Amersham, Little Chalfont, United Kingdom). The PCR products (10 p.l) were added to 40 ,ul of Tris-EDTA buffer and heat denaturated for 10 min. The samples were then applied to a nylon membrane (Hybond-N; Amersham) by using a Minifold I apparatus (Schleicher and Schuell, Dassel, Germany). The filters were dried, baked for 2 h at 80°C, and hybridized with the B. pertussis probe according to the manufacturer's instructions. The detection of the fluorescein-labelled probe was performed by use of horseradish peroxidase-labelled anti-fluorescein antibodies (Amersham) with the Amersham enhanced-chemiluminescence system. Serological assays. The detection of anti-PT antibodies in serum was performed with purified PT antigen and Western blot as previously described (lOa). The immunochemical detection was performed with peroxidase-labelled anti-human immunoglobulins with the Amersham enhancedchemiluminescence system, which has several advantages, including high sensitivity (the first serum dilution that can be used is 2 x 10-3 and not 1 x 10-1 or 1 x 10-2) and rapidity (maximum of 30 min until revelation of the reaction). With this detection system, blackening of the X-ray film is proportional to the sample light emission. In order to compare the results obtained with paired serum samples, the treated membranes were exposed to X-ray films for three different times: 6 s, 1 min, and 10 min. Detection of the immune complex was classified as ++ + after 6 s, + + after 1 min, and + after 10 min, no detection after 10 min was classified as -. An increase in the signal detection from + to + + + was considered significant.
RESULTS
Sensitivity and specificity of the PCR amplification. PCR was used to detect B. pertussis by using the pt promoter (27) , produced a positive signal. The sensitivity of the PCR reaction was determined by using a boiled suspension of B. pertussis Tohama strain, serially diluted to obtain decreasing concentrations of bacteria (from 106 organisms to 100). By this method, we were able to detect less than 102 organisms on the agarose gel and 101 organisms after dot blot hybridization with a fluorescein-labelled probe, which is in agreement with Houard et al., who used a 32P-labelled probe (15) . To determine the specificity of the oligonucleotide primers for B. pertussis, 2 B. parapertussis strains, 10 B. bronchiseptica strains, and 1 B. avium strain were tested by using these primers and the same hybridization conditions for PCR. We confirmed the data reported by Houard et al. (15) : all B. pertussis strains possessing the pt promoter were positive by PCR and all B. parapertussis, B. bronchiseptica, and B. avium strains were negative. Furthermore, we tested the specificity of the primers with purified DNA obtained from different bacterial and fungal strains liable to contaminate nasopharyngeal aspirates upon collection (Corynebacterium spp., Staphylococcus aureus, Mycoplasma pneumoniae, Legionella pneumophila, Aspergillus spp., and Candida albicans). None of these DNA samples demonstrated positive amplification of the pt promoter region by PCR.
Bacterial culture and PCR results. Thirty-seven patients (24 infants and children with cases of pertussis [ Table 1 ] and 13 adult contacts [ Table 2 ]) belonging to 23 different families (patients 3 and 14 were sisters) each had a nasopharyngeal aspirate cultured and tested by PCR.
Among the 24 pertussis-infected infants and children, 54.1% (13 of 24) had a nasopharyngeal-positive culture, and 95.8% (23 of 24) were positive by PCR ( Table 1 ). All of the 13 samples positive by culture were also positive by PCR (Table 1) . Among the 24 infants and children, 10 of 17 had received oral antibiotics prior to the nasopharyngeal aspirate collection-5 of 9 were culture positive (4 macrolide and 1 cephalosporin), and 5 of 8 were culture negative (3 macrolide and 2 amoxicillin).
Among the 13 adults with pertussis identified within the household, only 15.4% (2 of 13) were positive by culture and 61.5% (8 of 13) were positive by PCR (Table 2 ). Here again, the two samples positive by culture were positive by PCR. However, it has to be noted that two adults (no. 35 and 36) were positive by PCR and had detectable anti-PT antibodies in serum but did not exhibit any clinical symptoms ( Table 2 ).
As shown in Table 2 , four symptomatic and serologically confirmed cases of pertussis (no. 31 to 34) were detected neither by culture nor by PCR. No data concerning antibiotic treatments were available for these adults.
All of the 20 negative controls tested in this study were negative by culture and by PCR, and no antibodies were detected in their serum samples.
DISCUSSION
We voluntarily limited our study to B. pertussis infections. Thus, we chose a single antigen, PT, for serology and the PT promoter sequence as the PCR target because of their high specificity to B. pertussis. We also chose a strict case definition of pertussis for this first epidemiological PCR study in order to validate the assay. All of the children coughed for more than 21 days, all but 2 of our patients had detectable anti-PT antibodies in serum, and a significant increase of anti-PT antibodies was found for most of our patients (29 of 37). This may have increased the sensitivity of our PCR assay. However, the choice of a single copy sequence and the absence of internal control for amplification may, in turn, have limited this sensitivity.
The overall sensitivity (adults, infants, and children combined) of the nasopharyngeal culture (40.5%) was comparable to those in many pertussis studies (11, 26) . The sensitivity of the nasopharyngeal culture was higher in the group of infants and children (54.1%) than in the group of adults (15.4%). Lower sensitivity of culture in adults compared with children has been reported (28) . This result can be attributed to the particularly long duration of the cough in our adult series. No relationship between antibiotic therapy and culture result could be demonstrated, but few data were available. In comparison, the PCR method had greater sensitivity both in infants and children and in adults (95.8 and 58%, respectively). In the adult group, four symptomatic and serologically confirmed cases of pertussis were not detected by culture and PCR. Our choice of a single copy sequence as the PCR target may be responsible for reduced sensitivity of the PCR for samples containing few bacteria. This result demonstrates, however, that although it is very sensitive, PCR cannot detect all cases of pertussis. Pertussis-specific serology presently remains the reference technique for pertussis diagnosis in epidemiological studies.
Ten of 13 adults had a prolonged cough and detectable anti-PT antibodies in their serum samples, and were considered as having cases of pertussis according to the definition used in this study. Two of them had a positive nasopharyngeal culture, four others had detectable anti-PT antibodies in the second serum sample but not in the first serum sample, and two others had a significant increase in the level of the anti-PT antibodies when the first and second serum samples were compared. These results can be considered to be evidence of recent pertussis infection. The remaining two adults, however, each had only one serum sample available in which anti-PT antibodies were detected with a strong signal. The hypothesis that the presence of these antibodies could be the consequence of past immunization or infection is unlikely. Indeed, preliminary data collected from a serological study recently conducted in the French population showed that less than 20% of the individuals aged more than 15 years possessed detectable anti-PT antibodies despite previous pertussis immunization (unpublished data) or infection. This observation corroborates the fact that anti-PT antibody levels decrease rapidly in the absence of booster immunization.
Three adults had a positive detection of anti-PT antibodies in serum and did not cough despite an intrafamilial contact with a confirmed case of pertussis. One of them had detectable anti-PT antibodies in the second serum sample but not in the first serum sample and was culture negative and PCR negative. The two others had serological evidence of pertussis, and the PCR result was positive but the culture was negative. These two cases of infection are difficult to interpret, considering that these adults did not cough. Two hypotheses can be suggested to explain this result. First, these adults were simply colonized, and a booster effect was observed. Such an observation has been previously reported in a study in which adult contacts with cases of pertussis had a positive nasopharyngeal culture and serologic evidence of pertussis infection but no clinical symptoms (18) . Second, contamination might have occurred during specimen collection or processing. Such a hypothesis can never definitively be ruled out in a PCR study. However, the absence of false-positive PCR results in the control group gives some guarantees concerning the quality of our results.
Since we started this study, two other studies using PCR in clinical samples from pertussis-infected patients have been reported (14, 24) . Both studies used the repetitive sequence described by Glare et al. (10) and suggested that this sequence was specific for B. pertussis. However, only a few B. bronchiseptica strains were tested for specificity. The interpretation of the results reported by Olcen et al. (24) is hindered by the absence of clear definition of the cases of pertussis and by the lack of correlation with serological data. In the study by He et al. (14) , the PCR results were correlated with clinical data (duration of cough), culture, and serology by using an enzyme immunoassay with three purified antigens (PT, filamentous hemagglutinin, and pertactin). A significant increase in only two of the three corresponding antibodies was considered to be evidence of a recent case of pertussis. This suggests that some patients with no anti-PT antibodies were considered to be infected with B. pertussis. These patients could as well have been infected by B. parapertussis and B. bronchiseptica, two Bordetella species which do not synthesize PT. This may in part explain the lower rates of positivity by culture and PCR observed in their study, in addition to the fact that their patients were older (children and adults) and had been previously immunized.
Although limited to a small number of patients, especially adults, our results are encouraging and suggest that PCR could represent an interesting complementary tool for direct diagnosis of pertussis. A larger prospective clinical study will be necessary to confirm these results. In our study, rapidity was an advantage with PCR because the complete procedure took 3 days compared with 6 to 8 days for conventional culture. However, because of the necessity for multiple precautions to avoid bacterial and DNA contamination, PCR requires a well-trained operator using different PCR-dedicated rooms. For this reason, the PCR method presently does not seem to be a routine procedure and the nasopharyngeal culture is still the reference diagnostic method for routine diagnosis of pertussis. However, because of its high sensitivity and specificity, the PCR technique, in association with serology, promises to be a valuable diagnostic tool for epidemiological studies.
